These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
he product will be launched shortly in the US market.
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
